These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 15583857

  • 1. Dysfunction of the RET receptor in human cancer.
    Santoro M, Carlomagno F, Melillo RM, Fusco A.
    Cell Mol Life Sci; 2004 Dec; 61(23):2954-64. PubMed ID: 15583857
    [Abstract] [Full Text] [Related]

  • 2. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation.
    Peterson S, Bogenmann E.
    Oncogene; 2004 Jan 08; 23(1):213-25. PubMed ID: 14712226
    [Abstract] [Full Text] [Related]

  • 3. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
    Castellone MD, Celetti A, Guarino V, Cirafici AM, Basolo F, Giannini R, Medico E, Kruhoffer M, Orntoft TF, Curcio F, Fusco A, Melillo RM, Santoro M.
    Oncogene; 2004 Mar 18; 23(12):2188-96. PubMed ID: 14981541
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Lee RH, Wong WL, Chan CH, Chan SY.
    J Neurosci Res; 2006 Jan 18; 83(1):80-90. PubMed ID: 16294336
    [Abstract] [Full Text] [Related]

  • 5. A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.
    Gujral TS, van Veelen W, Richardson DS, Myers SM, Meens JA, Acton DS, Duñach M, Elliott BE, Höppener JW, Mulligan LM.
    Cancer Res; 2008 Mar 01; 68(5):1338-46. PubMed ID: 18316596
    [Abstract] [Full Text] [Related]

  • 6. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
    Sawai H, Okada Y, Kazanjian K, Kim J, Hasan S, Hines OJ, Reber HA, Hoon DS, Eibl G.
    Cancer Res; 2005 Dec 15; 65(24):11536-44. PubMed ID: 16357163
    [Abstract] [Full Text] [Related]

  • 7. Dysregulated RET signaling in thyroid cancer.
    Castellone MD, Santoro M.
    Endocrinol Metab Clin North Am; 2008 Jun 15; 37(2):363-74, viii. PubMed ID: 18502331
    [Abstract] [Full Text] [Related]

  • 8. The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.
    Boulay A, Breuleux M, Stephan C, Fux C, Brisken C, Fiche M, Wartmann M, Stumm M, Lane HA, Hynes NE.
    Cancer Res; 2008 May 15; 68(10):3743-51. PubMed ID: 18483257
    [Abstract] [Full Text] [Related]

  • 9. [Study on perineural infiltration in bile duct neoplasm--with special reference to the relationship with RET].
    Fukuyoshi I.
    Hokkaido Igaku Zasshi; 2005 Jan 15; 80(1):21-30. PubMed ID: 15796028
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of RET tyrosine kinase by SU5416.
    Mologni L, Sala E, Cazzaniga S, Rostagno R, Kuoni T, Puttini M, Bain J, Cleris L, Redaelli S, Riva B, Formelli F, Scapozza L, Gambacorti-Passerini C.
    J Mol Endocrinol; 2006 Oct 15; 37(2):199-212. PubMed ID: 17032739
    [Abstract] [Full Text] [Related]

  • 11. A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.
    Vanhorne JB, Andrew SD, Harrison KJ, Taylor SA, Thomas B, McDonald TJ, Ainsworth PJ, Mulligan LM.
    Oncogene; 2005 Feb 03; 24(6):1091-7. PubMed ID: 15592530
    [Abstract] [Full Text] [Related]

  • 12. New molecular targeted therapies in thyroid cancer.
    Milano A, Chiofalo MG, Basile M, Salzano de Luna A, Pezzullo L, Caponigro F.
    Anticancer Drugs; 2006 Sep 03; 17(8):869-79. PubMed ID: 16940797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemical localization of RET rearrangements in a Malaysian papillary thyroid carcinoma population.
    Omar E, Othman NH.
    Med J Malaysia; 2003 Aug 03; 58(3):461-2. PubMed ID: 14750392
    [No Abstract] [Full Text] [Related]

  • 15. Subcellular receptor redistribution and enhanced microspike formation by a Ret receptor preferentially recruiting Dok.
    Stenqvist A, Lundgren TK, Smith MJ, Hermanson O, Castelo-Branco G, Pawson T, Ernfors P.
    Neurosci Lett; 2008 Apr 11; 435(1):11-6. PubMed ID: 18353552
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of the activation mechanism of the multicomponent growth-factor receptor Ret.
    Schlee S, Carmillo P, Whitty A.
    Nat Chem Biol; 2006 Nov 11; 2(11):636-44. PubMed ID: 17013378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.